Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion type Assertion NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_head.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion description "[Moreover, targeting RSK2 markedly attenuates in vitro invasion and in vivo metastasis of HNSCC cells, suggesting that RSK2 may represent a therapeutic target in the treatment of metastatic HNSCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_provenance.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion evidence source_evidence_literature NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_provenance.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion SIO_000772 20234090 NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_provenance.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion wasDerivedFrom befree-20140225 NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_provenance.
- NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_assertion wasGeneratedBy ECO_0000203 NP499766.RA0wcyyFfxP-sWrtRjKGDGQtC0pAeDVMV1XrMQ-NfELHY130_provenance.